Health Professional Radio | 10.19.20

Sema4 – COVID-19 Viral and Antibody Testing

Health Professional Radio conducted an interview with Dr. Jamie Coffin, Sema4 President and COO. Among other things, he covered Sema4’s large-scale and accurate COVID-19 testing, Sema4’s COVID-19 testing solutions for schools and universities, and the importance of testing.

The Wall Street Journal | 10.13.20

Help Wanted at COVID-19 Testing Labs

The Wall Street Journal quoted Sema4 President & COO Jamie Coffin, Ph.D. in a story on laboratory technologists. He discussed Sema4’s plans to further build out its team of lab techs.

TrialSite News | 09.30.20

Sema4 Gives Janssen Access to Potential Competitive Advantage in Recruiting Oncology Patients

TrialSite News featured Sema4’s research agreement with Janssen Research & Development, LLC. The piece examines how Sema4 and Janssen will collaborate to identify patients diagnosed with cancer who could be possible candidates for oncology trials.

Sema4 Press Release | 09.30.20

Sema4 Appoints Human Resources Executive Karen White as Chief People Officer

Sema4 has announced that Karen White will lead the company’s human capital organization. She brings significant experience in strategy, organization, and leadership development, and human resources.

Fierce BioTech | 09.29.20

Janssen Teams up with Sema4 for Cancer Trial Matchmaking Service

Fierce BioTech published a story on Sema4’s collaboration with Janssen Research & Development, LLC. The article covers what Sema4 and Janssen are doing together to optimize oncology clinical trials.

Sema4 Press Release | 09.29.20

Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials

Sema4 has entered into a research agreement with Janssen Research & Development, LLC to leverage advanced data analytics and genomic testing to improve recruitment of patients in oncology clinical trials.

Sema4 Press Release | 08.13.20

Sema4 Named to the 2020 CB Insights Digital Health 150

Sema4 has been recognized by CB Insights in its annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world.

Bloomberg Radio | 08.12.20

Strategies for Improving Coronavirus Testing

Bloomberg Radio conducted a live interview with Dr. Eric Schadt, Sema4 Founder and CEO. Among other things, he covered the current status of COVID-19 testing in the U.S. and the work Sema4 is doing to combat COVID-19. Dr. Schadt’s interview starts at five minutes and 48 seconds in the link below.
TechCrunch | 07.29.20

Using population health analysis to improve patient care brings Sema4 a $1.1 billion valuation

Sema4’s $121 million financing came from BlackRock, Deerfield and Moore Strategic Ventures, and follows only 12 months after another $120 million institutional financing from investors, including Blackstone, Section 32, Oak HC/FT, Decheng and the Connecticut Innovation Fund.

Sema4 Press Release | 07.29.20

Sema4 Closes $121 Million Series C Led by BlackRock

Sema4 announces that BlackRock led its oversubscribed Series C financing of $121 million at a post-money valuation of over $1 billion. Additional new investors include Deerfield and Moore Strategic Ventures.